Links
- ORCID
- ORCID
- ORCID
- ORCID
- ORCID
- Crossref | PDF
- [www.ncbi.nlm.nih.gov] | PDF
- [push-zb.helmholtz-muenchen.de]
- [dx.doi.org] | PDF
- [boris.unibe.ch]
- [repository.tue.nl] | PDF
- [www.researchgate.net] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
- [europepmc.org] | PDF
- [repository.ubn.ru.nl] | PDF
- [boris.unibe.ch] | PDF
- [pure.rug.nl] | PDF
- [pure.tue.nl] | PDF
- [www.rug.nl] | PDF
Tools
ImmunoChip Study Implicates Antigen Presentation to T Cells in Narcolepsy
Abstract
Other ; Recent advances in the identification of susceptibility genes and environmental exposures provide broad support for a post-infectious autoimmune basis for narcolepsy/hypocretin (orexin) deficiency. We genotyped loci associated with other autoimmune and inflammatory diseases in 1,886 individuals with hypocretin-deficient narcolepsy and 10,421 controls, all of European ancestry, using a custom genotyping array (ImmunoChip). Three loci located outside the Human Leukocyte Antigen (HLA) region on chromosome 6 were significantly associated with disease risk. In addition to a strong signal in the T cell receptor alpha (TRA@), variants in two additional narcolepsy loci, Cathepsin H (CTSH) and Tumor necrosis factor (ligand) superfamily member 4 (TNFSF4, also called OX40L), attained genome-wide significance. These findings underline the importance of antigen presentation by HLA Class II to T cells in the pathophysiology of this autoimmune disease.